Vivus is a biopharmaceutical company engaged in the development and commercialization of therapeutic drugs for underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. Co.'s investigational drug pipeline includes two late-stage clinical investigational drug candidates: Qnexa for the treatment of obesity, diabetes and obstructive sleep apnea; and Avanafil the treatment of erectile dysfunction. In addition, Co. has licensed the rights to other investigational drug candidates to treat various diseases and medical conditions. Co. also sponsors early stage clinical trials at various research institutions.

VVUS — Key Stats (updated Friday, May 17, 10:22 AM)

Company Name:  Vivus, Inc. Website:  www.vivus.com Sector:  Drugs & Pharmaceuticals Number of ETFs Holding VVUS:  35 Total Market Value Held by ETFs:  $84,994,544 Total Market Capitalization:  $1,300,000,000 % of Market Cap. Held by ETFs:  6.54%

ETFs Holding VVUS

ETF   VVUS Weight   VVUS Amount   IWM   0.09%   $18,388,026           XPH   4.02%   $16,319,562           PJP   2.41%   $12,082,746           IBB   0.30%   $10,020,370           IWO   0.18%   $8,283,948           IHE   1.30%   $6,105,297           VBK   0.13%   $3,688,303           VB   0.05%   $3,462,335           VTI   0.01%   $2,196,546           VHT   0.06%   $924,570          List of all 35 ETFs holding VVUS »

VVUS — News

Featured Slideshows

10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites 25 Top Ranked Socially Responsible Dividend Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 ETFs Crossing Above Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg

Advertising Opportunities on ETF Channel